Gujarat Inject (Kerala) Ltd
BBSE:GUJINJEC9.79
INR
+0.46
(+4.93%)
ISIN
INE659F01022
Return %
Stock
S&P 500
1Y
379.20
14.20
3Y
958.38
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Anar C. Patel
- Full Time Employees
- 4
- Sector
- Distribution services
- Industry
- Medical distributors
- Address
- SB-06, Paradise Complex Vadodara GJ India 390005
- IPO Date
- Jan 1, 2008
- Website
- gujaratinject.in
- Similar Companies
- Business
- Gujarat Inject (Kerala) Ltd. manufactures and markets pharmaceutical and medical products primarily focused on intravenous (IV) fluids, infusion and transfusion solutions; bulk drugs and formulation chemicals; medicinal preparations including vitamin and non-vitamin tablets, capsules, and liquid formulations; and medical equipment such as disposable plastic bottles, surgical sets, infusion and transfusion sets, disposable syringes, and diagnostic kits. The company operates manufacturing facilities in Kerala, including at Puddussey East, Kanjikode in Palghat district, where it holds State Industrial Area (SIA) registration for producing intravenous solutions in aseptic bottles. Gujarat Inject (Kerala) Ltd. also engages in the trade, import, export, stocking, and distribution of these pharmaceutical and medical products. Founded in 1991 and headquartered in Kerala, the company is a joint sector enterprise promoted by Gujarat Inject Limited, Baroda, and its associates in partnership with the Kerala State Industrial Development Corporation Limited, a wholly-owned subsidiary of the Government of Kerala. This strategic alliance situates the company within the pharmaceutical manufacturing industry, catering to healthcare providers and institutions across India. In recent developments, Gujarat Inject (Kerala) Ltd. has entered into an Investment Sale Agreement with Soleos Energy Private Limited as part of its strategic business operations. The company has reported significant growth in sales, indicating an expansion phase. It continues to focus on enhancing its pharmaceutical product portfolio and production capacities, specifically in intravenous fluids and associated medical disposables, reinforcing its presence in the healthcare and medical supplies sector. The company serves primarily the Indian market with a focus on Kerala and adjoining regions, offering a diversified range of pharmaceutical and medical products essential for hospital and healthcare applications. Gujarat Inject (Kerala) Ltd. maintains operational focus on compliance, product quality, and expansion of manufacturing capabilities to sustain its growth trajectory and market presence. This description captures Gujarat Inject (Kerala) Ltd.'s core business activities, product offerings, key partnerships, and recent strategic moves reflective of its current operational status and industry positioning.